Moving Beyond the Sandbox: How to Build Inspection-Ready AI in Regulated Life Sciences
For years, AI was just a tool for simple tasks like drafting emails. Those days of casual use are over. Regulators are tightening expectations, demanding strict AI governance, perfect traceability, and full integration with quality compliance systems. These rules are no longer optional best practices.
How to REMS – A Practical Regulatory Guide
Risk Evaluation and Mitigation Strategies, or REMS, are required by the FDA for certain drugs with serious safety concerns. The goal of a REMS program is to ensure that the benefits of a drug outweigh its risks.
Audit & Inspection Readiness
Inspections and audits allow the pharmaceutical sponsor to improve its processes and demonstrate continual improvement in every department and phase of the process.